MedTrace Logo

Proof of Concept (POC) Study of the Soliton Rapid Acoustic (RAP) for the Treatment of Cellulite

NCT03981198 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-09-28

No results posted yet for this study

Summary

Feasibility study is to evaluate the safety, tolerability and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the treatment of cellulite

Conditions

  • Cellulite

Interventions

DEVICE

Soliton Rapid Acoustic Pulse (RAP)

Treatment of legs and/or buttocks for the temporary improvement in the appearance of cellulite.

Sponsors & Collaborators

  • Soliton

    lead INDUSTRY

Principal Investigators

  • Christopher C Capelli, MD · Soliton

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2019-08-05
Completion
2019-08-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03981198 on ClinicalTrials.gov